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OBJECTIVE — A prospective study of the impact of obesity on pregnancy outcome in glu-
cose-tolerant women.
RESEARCH DESIGN AND METHODS — The Irish Atlantic Diabetes in Pregnancy
network advocates universal screening for gestational diabetes. Women with normoglycemia
and a recorded booking BMI were included. Maternal and infant outcomes correlated with
booking BMI are reported.
RESULTS — A total of 2,329 women fulﬁlled the criteria. Caesarean deliveries increased in
overweight (OW) (odds ratio 1.57 [95% CI 1.24–1.98]) and obese (OB) (2.65 [2.03–3.46])
women.HypertensivedisordersincreasedinOW(2.30[1.55–3.40])andOB(3.29[2.14–5.05])
women. Reported miscarriages increased in OB (1.4 [1.11–1.77]) women. Mean birth weight
was 3.46 kg in normal BMI (NBMI), 3.54 kg in OW, and 3.62 kg in OB (P  0.01) mothers.
Macrosomia occurred in 15.5, 21.4, and 27.8% of babies of NBMI, OW, and OB mothers,
respectively (P  0.01). Shoulder dystocia occur in 4% (4 kg) compared with 0.2% (4 kg)
babies (P  0.01). Congenital malformation risk increased for OB (2.47 [1.09–5.60]) women.
CONCLUSIONS — OW and OB glucose-tolerant women have greater adverse pregnancy
outcomes.
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O
besity is now a global pandemic (1)
and increases the risk of gestational
diabetesmellitus(GDM).Fewstud-
ies (2,3) have examined the independent
effects of obesity on pregnancy outcome
in glucose-tolerant women.
RESEARCH DESIGN AND
METHODS— The Atlantic Diabetes
in Pregnancy Partnership (ATLANTIC
DIP) (4), serving a population of 500,000
in ﬁve centers along the Irish Atlantic sea-
board, advocates and provides universal
screening for GDM using a 75-g oral glu-
cose tolerance test (OGTT) at 24–28
weeks. Normoglycemia is deﬁned as a
fasting blood glucose 5.6 mmol/l and
2-h value 7.8 mmol/l (5). Maternal BMI
(kg/m
2) was calculated at the ﬁrst obstet-
rical visit and deﬁned as 25 kg/m
2 nor-
mal BMI (NBMI), overweight (OW) 25–
29.9 kg/m
2, and obese (OB) 30 kg/m
2.
Maternal outcomes included caesarean
deliveries, antepartum (APH) and post-
partum (PPH) hemorrhage, pregnancy-
induced hypertension (PIH), and
preeclampsia (PET). Fetal/infant out-
comes included gestational weight at
delivery, macrosomia, shoulder dysto-
cia, major congenital malformations,
miscarriage, stillbirth, neonatal death,
and perinatal mortality. Statistical anal-
yses were carried out using the Statisti-
cal Package for the Social Sciences
version 15.0. Signiﬁcance was achieved
at P  0.05.
RESULTS
Maternal outcomes
A total of 2,329 women, mean  SD age
31.4  5.4 years, 90% Caucasian with a
recorded booking BMI and a normal
OGTT,wereincluded.Caesareandeliver-
ies increased from 16.4 to 23.4 to 32.6%
in NBMI, OW, and OB women, respec-
tively(P0.01).Theoddsratio(OR)ofa
caesarean delivery was 1.57 (95% CI
1.24–1.98, P  0.01) for OW and 2.65
(2.03–3.46,P0.01)forOBwomen(Ta-
ble1).Theriskofanemergencycaesarean
delivery increased from 10 to 12.4 to
16.1% in NBMI, OW, and OB women,
respectively (P  0.01). The trend was
similar for elective caesarean delivery, in-
creasing from 6.5 to 11 to 16.5% NBMI,
OW, and OB women, respectively (P 
0.01). There was no correlation between
increasing maternal age and increasing
BMI.
PIH increased from 4.3 to 9 to 11.3%
in NBMI, OW, and OB women, respec-
tively (P  0.01). PET risk doubled from
2.7 to 4.7 to 6% in NBMI, OW, and OB
women, respectively (P  0.01). The
overall risk of hypertensive disorders in-
creased from 5 to 9.7 to 12.7% in NBMI,
OW, and OB women, respectively (P 
0.01). The OR of having a pregnancy
complicated by hypertension was 2.30
(95%CI1.55–3.40,P0.01)inOWand
3.29(2.14–5.05,P0.01)inOBwomen
(Table 1). There was no signiﬁcant differ-
ence in the rates of APH or PPH between
groups.
Fetal/infant outcomes
A total of 41.2% of OB women had a his-
tory of more than one miscarriage, com-
pared with 34.7 and 32.5% in OW and
NBMI women, repectively (P  0.01).
TheORofahistoryofmiscarriagewas1.4
(95% CI 1.11–1.77 in OB women, P 
0.01). There was a linear increase in birth
weight across each BMI group. Mean (
SD)birthweightwas3.460.53,3.54
0.59, and 3.62  0.55 kg in babies of
NBMI, OW, and OB women, respectively
(P  0.01). The percentage of macro-
somicbabies(4kg)increasedfrom15.5
to 21.4 to 27.8% in NBMI, OW, and OB
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4.1% of babies (4 kg) compared with
0.2%ofbabies(4kg)hadshoulderdys-
tocia (P  0.01). Thirty-seven babies
(1.6%) had congenital malformations.
The OR of a malformation was 2.47
(1.09–5.60, P  0.03) in OB women.
Fourteen (0.6%) stillbirths and two
(0.1%) neonatal deaths occurred with a
PMRof6of1,000.BMIwasnotapositive
predictor for these outcomes.
CONCLUSIONS — Obesity is a risk
factor for adverse pregnancy outcome,
but the potential contribution from undi-
agnosed hyperglycemia is not always ex-
cluded (6–8). We excluded diabetes and
demonstrated increased adverse events
with increased BMI. Rates of emergency
caesarean delivery/elective caesarean de-
livery increased in OW and OB women.
The higher rates of emergency caesarean
delivery are likely to be more than a re-
ﬂection of local obstetric practice, as
14.2% infants delivered by emergency
caesarean delivery versus 6% by elective
caesarean delivery and 3.6% vaginally
were admitted to the neonatal intensive
care unit (P  0.01). Prevalence of PIH/
PET was increased in OW and OB
women.Anoverviewof13studiesinvolv-
ingamillionwomensuggeststhattherisk
of PET doubles with every 5–7 kg/m
2 in-
crease in BMI (9). Our ﬁndings were
broadlysimilarwithanapproximatedou-
bling of risk of PIH in the presence of
obesity. This is a signiﬁcant ﬁnding given
that hypertensive disorders are the third
leadingcauseofmaternaldeath(10),with
a suggestion that long-term cardiovascu-
lar mortality may be increased (6).
Macrosomia is more common in OB
women (11). In addition to birth injury,
macrosomiaislinkedtoincreasedobesity
and dysglycemia in adolescence (12). We
found a strong association between obe-
sity, macrosomia, and shoulder dystocia.
A meta-analysis by Stothard et al. (13)
showed that obese women are at in-
creased risk of congenital malformations.
The authors recognized in their conclu-
sion that some of these adverse outcomes
may be due to undiagnosed hyperglyce-
mia. We found a signiﬁcantly higher rate
of congenital malformations in OB
women (OR 2.47) but had excluded
diabetes.
Previous studies have tried to disen-
tangle the effects of obesity and diabetes
on pregnancy outcome. Jensen et al. (2)
found an increased risk of adverse events
in OW/OB glucose-tolerant Danish
women. These women were selected on
the basis of increased risk of GDM,
thereby limiting the application of the
ﬁndings to the general population. Our
study was in an unselected population of-
fered universal screening for GDM, and
the results are therefore more applicable
to the general obstetric population. In an
earlier study, Jensen demonstrated in-
creasing risk of shoulder dystocia and
macrosomia with increasing increments
in fasting and 2-h glucose values, but pa-
tients with impaired glucose tolerance
were not excluded (3). We recognize that
despite excluding women with GDM/
impaired glucose tolerance, there is evi-
dence that even lesser degrees of hy-
perglycemiamaystillcarryadditionalrisk
of adverse outcomes, as demonstrated in
the Hyperglycemia and Adverse Preg-
nancy Outcome (HAPO) study (14).
Obesity confers an increased lifetime
risk for type 2 diabetes, and research has
offered potential interventions to retard
this (15). Identifying obese women and
providing interventions is essential for
long-term diabetes prevention. Obese
women could be offered prepregnancy
care with a focus on promoting NBMI
prior to their next pregnancy. This would
potentially reduce adverse maternal out-
comes. Reducing BMI would also affect
the offspring in the antenatal and postna-
tal periods. Further studies are needed to
compare outcomes of obese women who
undergo intensive prepregnancy care com-
pared with those with no intervention.
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